Francois Brisebois
Stock Analyst at LifeSci Capital
(3.90)
# 1,890
Out of 4,969 analysts
389
Total ratings
42.8%
Success rate
5.2%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics | Reiterated: Buy | $75 → $78 | $40.25 | +93.79% | 32 | Sep 14, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $20 | $5.97 | +235.01% | 16 | Sep 12, 2026 | |
| APMD Apnimed | Reiterated: Buy | $50 | $25.55 | +95.69% | 3 | Sep 9, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $24 | $14.54 | +65.06% | 18 | Sep 9, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $44 → $40 | $18.52 | +115.98% | 32 | Sep 8, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $30.51 | $13.51 | +125.86% | 2 | Aug 29, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $37 | $13.15 | +181.37% | 6 | Aug 14, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $5 | $2.74 | +82.48% | 15 | Aug 14, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $10 | $4.88 | +104.92% | 19 | Aug 13, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $5.34 | +87.27% | 32 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $719 → $754 | $330.55 | +128.10% | 31 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $95 → $104 | $79.95 | +30.08% | 30 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.78 | +561.38% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5407 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $41.54 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.42 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $80 | $39.09 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.43 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.46 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $7.05 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $7.23 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.23 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $13.88 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.55 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $20 | $1.33 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $60 | $1.88 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.99 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $100 | $0.000001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.7072 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $83.53 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.5 → $4 | $0.8902 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $15 | $0.0001 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $72 | $6.38 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.8848 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $1.62 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.631 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $1.83 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $0.079 | n/a | 1 | Feb 13, 2018 |
Definium Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $75 → $78
Current: $40.25
Upside: +93.79%
Opus Genetics
Sep 12, 2026
Reiterated: Buy
Price Target: $20
Current: $5.97
Upside: +235.01%
Apnimed
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $25.55
Upside: +95.69%
COMPASS Pathways
Sep 9, 2026
Reiterated: Buy
Price Target: $24
Current: $14.54
Upside: +65.06%
Dyne Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $44 → $40
Current: $18.52
Upside: +115.98%
Satellos Bioscience Inc.
Aug 29, 2026
Reiterated: Buy
Price Target: $30.51
Current: $13.51
Upside: +125.86%
MapLight Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $37
Current: $13.15
Upside: +181.37%
Ovid Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $2.74
Upside: +82.48%
Aquestive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $4.88
Upside: +104.92%
Savara
Aug 12, 2026
Reiterated: Buy
Price Target: $10
Current: $5.34
Upside: +87.27%
Aug 8, 2026
Rated: Buy
Price Target: $719 → $754
Current: $330.55
Upside: +128.10%
Aug 8, 2026
Rated: Buy
Price Target: $95 → $104
Current: $79.95
Upside: +30.08%
Aug 5, 2026
Reiterated: Buy
Price Target: $25
Current: $3.78
Upside: +561.38%
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.5407
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $41.54
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $18.42
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $4 → $80
Current: $39.09
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $5.43
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.46
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $7.05
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $7.23
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $8.23
Upside: n/a
Jul 29, 2024
Reiterated: Buy
Price Target: $36
Current: $13.88
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $6.55
Upside: n/a
Aug 17, 2023
Reiterated: Buy
Price Target: $90 → $20
Current: $1.33
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $8 → $60
Current: $1.88
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $5
Current: $1.99
Upside: n/a
Sep 27, 2022
Reiterated: Buy
Price Target: $80 → $100
Current: $0.000001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.7072
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $83.53
Upside: n/a
Sep 10, 2019
Reiterated: Buy
Price Target: $8.5 → $4
Current: $0.8902
Upside: n/a
Sep 4, 2019
Reiterated: Buy
Price Target: $23 → $15
Current: $0.0001
Upside: n/a
Sep 4, 2019
Reiterated: Buy
Price Target: $68 → $72
Current: $6.38
Upside: n/a
Jul 29, 2019
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.8848
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $1.62
Upside: n/a
Feb 20, 2019
Reiterated: Buy
Price Target: $11
Current: $0.631
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $1.83
Upside: n/a
Feb 13, 2018
Reiterated: Buy
Price Target: $210
Current: $0.079
Upside: n/a